Antibody-Drug Conjugate (ADC)

Antibody-Drug Conjugates (ADCs) are made by using a linker to join an antibody with some kind of chemical. These drugs benefit from the specificity of monoclonal antibodies and the toxicity of the chemical. As a consequence the treatment is less harmful to patients since it can kill the problem cells (usually cancer) without harming normal cells.

 

Don't see an employer? Please fill out the form